Examkin

Question

Difficulty: MediumStudy Design

A clinical research team is investigating a potential link between a newly approved monoclonal antibody therapy and the development of progressive multifocal leukoencephalopathy (PML), an extremely rare demyelinating disease. They query a multi-state hospital network's electronic health records to identify 30 patients diagnosed with PML over the past five years. For comparison, they randomly select 120 patients from the same network who have similar underlying autoimmune conditions but have never been diagnosed with PML. The researchers then review the historical pharmacy records of all 150 patients to ascertain their prior exposure to the monoclonal antibody. Which of the following statements regarding this study design are correct?

  1. A
    This methodology represents a retrospective cohort study because all analyzed exposure data was recorded prior to the investigation.
  2. B
    The researchers can directly determine the incidence rate of the demyelinating disease among patients exposed to the monoclonal antibody.
  3. The investigators can calculate an odds ratio to estimate the magnitude of the association between the therapy and the disease.Answer
  4. D
    Selecting a comparison group with similar underlying autoimmune conditions allows the researchers to evaluate the autoimmune condition as an independent risk factor.
  5. The chosen methodology is particularly well-suited for this investigation because the neurological outcome of interest has a very low prevalence.Answer

Answer

The correct statements are that the investigators can calculate an odds ratio to estimate the magnitude of the association, and that the chosen methodology is particularly well-suited for this investigation because the neurological outcome of interest has a very low prevalence.
The scenario describes a case-control study, as patients were grouped by their disease outcome (PML vs. no PML) before their past exposure to the monoclonal antibody was analyzed. Case-control studies are the optimal observational design for investigating rare diseases because they ensure an adequate sample of diseased subjects without requiring a massive, prolonged cohort study. Additionally, because the ratio of cases to controls is artificially selected by the researchers, it is mathematically impossible to calculate true incidence or relative risk; instead, the odds ratio is calculated to approximate the strength of the association.

Step-by-Step Solution

1
Identify the study design described in the clinical vignette.
The researchers identified subjects based on the presence of the disease (cases with PML) or the absence of the disease (controls without PML) and then looked back at historical records for exposure.
Grouping patients by outcome status rather than exposure status is the defining characteristic of a case-control study.
2
Determine the appropriate statistical measures and limitations for the identified design.
Case-control studies use the odds ratio to estimate association. They cannot measure incidence or true relative risk directly.
The investigator artificially sets the number of cases and controls, breaking the natural incidence rate found in the general population.
3
Evaluate the epidemiological indications for this specific study design.
The design is highly optimal for rare diseases like progressive multifocal leukoencephalopathy.
Following a healthy cohort forward to find enough cases of an extremely rare disease would be prohibitively expensive and time-consuming.
4
Analyze the effect of the control selection criteria.
Selecting controls with similar underlying conditions controls for confounding but prevents analyzing that specific condition as a risk factor.
If a variable is uniform or intentionally matched between the case and control groups, its independent effect on the outcome cannot be statistically evaluated.

Key Concept

Case-control studies identify subjects by disease status, utilize odds ratios to estimate association, are highly efficient for investigating rare diseases, and preclude the analysis of matched variables as independent risk factors.
Rate this question

Topics

Study Design

More questions from this topic